Emerging Cancer Molecular Diagnostic Tests

Date: December 22, 2011
Pages: 45
Price:
US$ 1,450.00 US$ 1,232.50
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C70D6A0C69AEN
Leaflet:

Download PDF Leaflet

Emerging Cancer Molecular Diagnostic Tests
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing.

Contains 45 pages and 1 table
1. OVERVIEW

2. MAJOR CANCER TYPES
  • Prostate
  • Lung
  • Colon and Rectum
  • Breast
  • Skin
  • Uterine
  • Leukemia
  • Oral

3. ONCOGENES
  • Abl/abl-bcr
  • AIB1
  • BRCA1
  • CD44
  • C-fos
  • C-myb
  • C-myc
  • CYP17
  • Erb-B
  • HPC1
  • N-myc
  • P40
  • P51
  • P53
  • PIK3CA
  • PTI-1
  • Ras
  • Reg
  • Sis
  • Src
Table: Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Skip to top


Ask Your Question

Emerging Cancer Molecular Diagnostic Tests
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: